GJ
G Leonard Baker Jr (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Corcept Therapeutics Incorporated (CORT). Across 1 priced purchase filing, the average 21-session return was +35.5% from execution and +40.1% from disclosure (delay-adjusted; derived). The largest single filing was $3.3M of CORT (100,000 sh across 2 lots, as filed), executed Mar 17. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+35.5%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+40.1%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.3M
shares × price, as filed
Last traded
Mar 17
Filed Mar 19
Median ADV $130.9M across their filed names
Open performance→Volume by month
Buys $3.3M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
CORTRecent filings
CORTPURCHASE
Corcept Therapeutics Incorporated
View filing →
$3.3M100,000 sh across 2 lots
Exec Mar 17
Filed Mar 19 · 5:07 PM ET